RaySearch Laboratories AB: Expanding Horizons in Cancer Care
In a significant development for RaySearch Laboratories AB, a leading medical technology company specializing in cancer treatment solutions, the firm has been selected by AKSM/Oncology to provide its cutting-edge RayCare and RayStation systems for a new cancer center in San Luis Obispo, California. This partnership, announced on July 21, 2025, marks a pivotal expansion for RaySearch as it continues to solidify its presence in the global oncology landscape.
The new center, named Advanced Radiation Therapeutics (ART), is a collaborative effort with Urology Associates of The Central Coast. It is set to open in March 2026, offering patients comprehensive cancer care utilizing RaySearch’s advanced software solutions alongside TrueBeam linear accelerators. This strategic move underscores RaySearch’s commitment to enhancing cancer treatment through innovative technology.
In parallel, RaySearch has entered into a strategic partnership with Radiology Oncology Systems, Inc. (ROS), aimed at expanding access to cancer care through the integration of refurbished linear accelerators with advanced software solutions. This collaboration, announced on July 18, 2025, has already resulted in agreements with centers in Argentina, demonstrating the potential for significant impact in emerging markets.
RaySearch’s RayStation system, a cornerstone of its product offerings, is renowned for its comprehensive treatment planning capabilities, including automated planning, adaptive therapy, and machine learning. The addition of RayCare, an oncology information system, further enhances the company’s ability to support a wide range of treatment planning activities.
With a market capitalization of 10.46 billion SEK and a robust price-to-earnings ratio of 55.2914, RaySearch’s financial health remains strong. The company’s strategic alliances and technological advancements position it well for continued growth in the competitive health care technology sector.
As RaySearch Laboratories AB continues to forge partnerships and expand its technological footprint, it remains at the forefront of innovation in cancer treatment, offering hope and advanced care solutions to patients worldwide.